fda semaglutide update Novo Nordisk has announced that the has approved the Wegovy® pill (once-daily oral 25 mg) as the first ever oral GLP-1 receptor agonist therapy for chronic weight management in adults Millions are trying FDA-authorized alternatives

(2019) 51:e13279

(US Institute of Medicine, 1994)

Smooth Recovery: Botox Aftercare with Celebrity Injector Melanie Speed, APRN, NP-C CANS What should I avoid after getting Botox

Speak with one of our healthcare specialists today to discuss your options and find the right care for you

We are excited to help pave the way, providing evidence of how these medications may impact our patients ocular health. Advertisement Advertisement New insights on effectiveness in patients previously treated with other anti-VEGF drugs CFH gene triggers the eye disease in white patients but not Black patients A primer on sustained release options Study explores association between sleep aid and eye disease Early data show risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis Switching medications may decrease treatment burden and macular fluid Why retina specialists should get comfortable with this imaging tool Large retrospective analysis may prompt prospective studies